Fire Resistant Glass Market Is Poised To Reach $7.28 Billion By 2024: Grand View Research, Inc.

The global Fire Resistant Glass Market is expected to reach USD 7.28 billion by 2024, according to a new report by Grand View Research, Inc. Rising demand for fire resistant glass owing to the increasing investments by the regional governments on infrastructure development in emerging regions including Asia Pacific and the Middle East is expected to drive the market over the next eight years.

Rising application scope in the marine industry pertaining to increasing demand for fire proof cabins in ships used for commercial and naval applications is expected to drive the demand over the next eight years. Moreover, rising investment in ship manufacturing activities from emerging economies such as China and India are expected to drive the demand over the forecast period.

Increased use of fire resistant automotive glass by the automotive manufacturers, on account of growing demand from consumers to enhance the safety standards of the vehicles is expected to propel the demand. Moreover, growing technological innovations along with rising fire safety standards of the vehicles globally are likely to augment demand over the next eight years.

Ceramic glass accounted for over 40% of the market in terms of volume on account of fire resistant and sound insulation properties. Growing use of the product in fire doors is likely to drive the market demand over next eight years.
Access Full Research Report on Fire Resistant Glass Market: www.grandviewresearch.com/industry-analysis/fire-resistant-glass-market

Further key findings from the report suggest:
  • The global fire resistant glass market demand was 13.4 million square meters in 2015 and is expected to reach 30.5 million square meters by 2024, recording a CAGR of 9.6% from 2016 to 2024.
  • Gel filled glasses are expected to be the fastest growing product segment registering a CAGR of over 15% from 2016 to 2024. Ability to maintain relatively low temperature on the non-fire side of the affected building by acting as a fire shield on account of the heat absorbing capabilities of the gel is likely to fuel the growth of fire resistant glass market over next eight years.
  • Other applications including automotive, oil & gas and, military & defense are expected to register a CAGR of around 9% from 2016 to 2024 accounting for 19.6% of total market volume in 2015. Rapid growth in the automotive industry in the emerging economies such as Asia Pacific and Latin America owing to increasing demand for automobiles and rising disposable income of consumers is expected to drive the growth over the forecast period.
  • Ceramic glass held the largest market share, owing to its wide application scope in various end use industries including construction, automotive, oil & gas, and marine. Growing application scope on account of its prolonged fire rating ranging from 20 minutes to 3 hours is expected to drive the market demand for the product over the forecast period.
  • Asia Pacific accounted for a significant market share of around 19% in 2015. Ready availability of raw material coupled with cheaper manufacturing costs are expected to drive the market growth. The region is also projected to witness the growth of 11% from 2016 to 2024.
  • The industry is moderately fragmented with the presence of a large number of prominent market participants across the globe. Some leading companies operating in the global market include Saint-Gobain, Pyroguard UK Ltd, Schott AG, NSG Pilkington, and Asahi Glass Co. Ltd. Saint-Gobain SA is a producer and distributor of construction and high-performance materials and packaging headquartered in France. The company operates in four business segments including innovative materials, high performance materials, construction products and building distribution.
  • In July 2015, Saint-Gobain agreed to buy Oregon-based Structus Building Technologies, a manufacturer of innovative, high-performance drywall corner solutions.

Grand View Research has segmented the fire resistant glass market by product, application, and region:

Global Fire Resistant Glass Product Outlook (Volume, Million Square Meter; Revenue, USD Billion, 2013 - 2024)
  • Wired
  • Ceramic
  • Tempered
  • Gel Filled
Global Fire Resistant Glass Application Outlook (Volume, Million Square Meter; Revenue, USD Million, 2013 - 2024)
  • Construction
  • Marine
  • Others
Global Fire Resistant Glass Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 - 2024)
  • North America
    • US
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
at No comments:

Genitourinary Drugs Market Is Estimated To Generate USD 29.7 Billion By 2024: Grand View Research, Inc.

The Genitourinary Drugs Market is expected to reach USD 29.7 billion by 2024, according to a new study by Grand View Research, Inc. This sector is expected to be driven by high R&D investments undertaken by the key companies, which is expected to result in the large-scale development of new drug candidates. This is presumed to increase the influx of drugs at a rapid pace into the genitourinary drugs market hence providing efficient treatment alternatives for numerous genitourinary disorders.

In addition, growing incidence of drug recalls is fueling the high clinical urgency to develop relatively new and advanced drugs with targeted therapy mechanisms. These factors cumulatively are slated to present the vertical with considerable growth opportunities over the forecast period.

Furthermore, increasing global presence of the major market players is anticipated to raise the awareness levels pertaining to treatment alternatives for genitourinary diseases amongst the patients as well as the physicians. This is further expected to widen the genitourinary market growth potential during the forecast period. Growing generic drugs competition, rising presence of counterfeit drugs, and with several patent expirations in the horizon, the market growth is expected to slow down over the coming years. 

Access Full Research Report on On Genitourinary Drugs Market: www.grandviewresearch.com/industry-analysis/genitourinary-drugs-market

Further Key Findings From the Study Suggest:
  • Prostate cancer held the largest share of the indication segment in 2015 owing to the rising global incidence of the condition. In addition, advances in proteomics technology and improved screening and diagnostic procedures are presumed to be responsible for the dominant share. 
  • Other products segment captured the majority share of 44.8% in the application segment in 2015. This is attributed to the numerous products launched by the major market players, which is responsible in widening the growth platform. For instance, in January 2016, ProstaPlast presented transdermal urological plasters in Europe, which demonstrated its clinical efficacy in reducing urinary problems in majority of the patients.
  • In 2015, North America dominated the global genitourinary drugs vertical with a share of over 42.6%. The dominant share is attributable to the high disease burden present in this region, thus driving the inclination of researchers and healthcare professionals toward advanced formulation technologies, which is anticipated to widen the growth scope for this sector.
  • Asia Pacific is expected to witness a lucrative CAGR of over 5.6% during the forecast period. The exponential growth rate can be attributed to the rising healthcare spending and the improving infrastructure quality of clinical research and manufacturing facilities owing to the initiatives of the key vertical players.
  • The prominent participants are employing new product development and collaborative strategies to capture greater market share and increase their presence in this sector. For instance, in March 2015, Novartis AG further enhanced its cancer immunotherapy research initiative through collaboration with Aduro Biotech to increase its activities toward discovery and development in next generation cancer immunotherapy.

Read Our Blog: www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the genitourinary drugs market on the basis of product, application, test, and region:
Global Genitourinary Drugs Indication Outlook (Revenue, USD Million, 2013 - 2024)
  • Prostate Cancer
  • Ovarian Cancer
  • Bladder Cancer
  • Cervical Cancer
  • Renal Cancer
  • Erectile Dysfunction
  • Urinary Tract Infections
  • Urinary Incontinence & Overactive Bladder
  • Sexually Transmitted Diseases
  • Interstitial Cystitis
  • Hematuria
  • Benign Prostatic Hyperplasia
Global Genitourinary Drugs Product Outlook (Revenue, USD Million, 2013 - 2024)
  • Urologicals
  • Hormonal Therapy Drugs
  • Gynecological products
  • Anti-infectives
  • Others
Genitourinary Drugs Regional Outlook (Revenue, USD Million, 2013 - 2024)
  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
at No comments:

HBOT Devices Market Is Poised To Reach $3.91 Billion By 2025: Grand View Research, Inc.

The global Hyperbaric Oxygen Therapy Devices Market is expected to reach USD 3.91 billion by 2025, according to a new report by Grand View Research, Inc. Growing inclination of healthcare professionals toward oxygen therapy, despite a lack of conclusive evidence is one of the key factors expected to drive the market over the coming few years.

Although the off-label usage of HBOT devices in various applications such as cancer and brain injury is controversial, the adoption rate of this technology is surging at a rapid pace. The high commercial availability of HBOT systems is one of the crucial factors that is anticipated to drive the market over the forecast period. However, few medical professionals are still skeptical about the usage of HBOT devices in unapproved applications, which is expected to impede growth. The technological advancements in this field such as portable HBOT system and growing awareness among healthcare professionals regarding the benefits of integrating ICU systems in multiplace HBOT equipment are some of the key contributors that are accountable for robust growth rate.
According to few publications, nearly 30,000 HBOT treatments are done on a daily basis globally. Other than the surging clinical prevalence and rising adoption of hospital setting HBOT systems, there is a considerable growth in popularity and demand for HBOT systems in home settings owing to its easy usage. Increasing private & public investment to expand geographical presence and surging R&D activities are also some of the factors that are anticipated to boost the demand.


Further Key Findings From the Report Suggest:
  • The global hyperbaric oxygen therapy (HBOT) market size was estimated at USD 2,210.5 million in 2016 and is expected to grow at a CAGR of 6.5% from 2017 to 2025
  • Monoplace HBOT Devices segment emerged as the largest product segment in 2016 and is estimated to generate revenue over USD 3,008.8 million by 2025
  • Other applications such as acute carbon monoxide poisoning, chemotherapy-induced hemorrhagic cystitis, and cyanide poisoning generated revenue of USD 229.1 million in 2016 and is anticipated to witness fastest growth over the next 8 years
  • The Asia Pacific region is anticipated to witness lucrative growth over the next decade owing to various developments in healthcare infrastructure and technological advancements in the medical device industry across major emerging economies. It is expected to grow at a CAGR of 7.1% over the forecast period.
  • Some of the key players including Fink Engineering; HAUX-LIFE-SUPPORT; ETC Hyperbaric Chambers (Environmental Tectonics Corporation); Gulf Coast Hyperbarics, Inc.; IHC Hytech B.V. (Royal IHC); HEARMEC; Hyperbaric; Sechrist Industries, Inc.; OxyHeal International; and SOS Group Global Ltd. dominated the global hyperbaric oxygen therapy devices market.
Grand View Research has segmented the global hyperbaric oxygen therapy (HBOT) devices market on the basis of product, application, and region:
HBOT Devices Product Outlook (Revenue, USD Million, 2014 - 2025)
  • Monoplace HBOT Devices
  • Multiplace HBOT Devices
  • Topical HBOT Devices
HBOT Devices Application Outlook (Revenue, USD Million, 2014 - 2025)
  • Wound Healing
  • Decompression Sickness
  • Infection Treatment
  • Gas Embolism
  • Others
HBOT Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
at No comments:

Influenza Diagnostics Market Is Poised To Reach $3.3 Billion By 2024: Grand View Research, Inc.

The Influenza Diagnostics Market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.



Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver accurate results in approximately 15 minutes. This factor deems them efficient, which has resulted in the lucrative growth of this segment with the fastest CAGR. Reverse transcription polymerase chain reaction (RT-PCR) holds the second highest market share following RIDTs, and this can be attributed to the fact that it provides detailed analytical results, sharper turnaround times, and high throughput.

Hospitals held the highest market share in 2015, but Point-of-Care Testing (POCT) is anticipated to overtake and lead the market in the coming future, owing to the increasing usage of POCT because of its ease of use and short turnaround times.North America dominates the market, due to a high focus of the government and healthcare bodies to control influenza.

Access Full Research Report on Influenza Diagnostics Market: www.grandviewresearch.com/industry-analysis/influenza-diagnostics-market

Further Key Findings From the Study Suggest:
  • North America is anticipated to dominate the global influenza diagnostics market. The high adoption rates of in vitro diagnostics and presence of technologically advanced medical devices is expected to drive growth in the region.
  • The Asia Pacific region is anticipated to be the fastest growing region in the study period. This growth is attributed to factors such as increasing initiatives by the countries to counter the incidence of the disease. For instance, CDC reached a cooperative agreement with South-East Asian Region to fund non research-related bilateral influenza as a measure to respond to avian, seasonal, and pandemic influenza.
  • The RIDT segment is expected to grow at a significant rate compared to others and accounts for the largest share in 2015.
  • This market comprises several local as well as global players. Some of the major players of this vertical include Becton, Dickinson and Company, Roche Diagnostics, Alere, Quidel Corporation, and Thermo Fisher Scientific.

Grand View Research has segmented the influenza diagnostics market on the basis of test type, end use, and region:
Test Type Outlook (Revenue, USD Million, 2013 - 2024)
  • RIDTs
  • RT-PCR
  • Cell Culture
  • Others
End-use Outlook (Revenue, USD Million, 2013 - 2024)
  • Hospital
  • Point-of-Care Testing
  • Laboratories
Regional Outlook (Revenue, USD Million, 2013 - 2024)
  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com
at No comments:

Integrated Pest Management Market Total Value Is To Be $151.0 Billion By 2025: Grand View Research, Inc.

The global Integrated Pest Management Market value is anticipated to reach USD 151.0 billion by 2025, according to a new report by Grand View Research, Inc. Favorable regulatory scenario banning the usage of pesticides and growing concerns regarding the diseases caused by insects are anticipated to favor industry growth.


IPM program is a systematic approach used for solving insect, weed, & diseases problems and prevent them from damaging crops, infesting buildings, & harming animals. It is the most effective and least-risk options for responding to the problem. The approach can be used to manage all kinds of insect anywhere such as in urban, wildland, agricultural, and natural areas.

The rising concern over harmful effects of pesticides on the environment is likely to enhance the popularity of the product. Some of the major application sectors of the industry include agriculture, commercial buildings, industrial, residential, and others. Agricultural is the largest application segment and is expected to follow the same growth trend over the forecast period, owing to its usage in controlling and preventing the insect from crops.

Invertebrates have emerged as the largest segment in 2016 followed by weeds, pathogens, and vertebrates. Change in climate conditions and rising temperature is anticipated to be the major factor for the growth of invertebrate. Invertebrates are generally the household insect including ants, cockroaches, flies, and caterpillars. They can harm the household farming thus leading to infect human health and environment. The IPM program and training may help in mitigating the risk of invertebrate control with reducing the utilization of chemicals and increasing efficiency.

Access Full Research Report on Integrated Pest Management Market: www.grandviewresearch.com/industry-analysis/integrated-pest-management-ipm-market

Further key findings from the report suggest:
  • The global demand for integrated pest management market was valued at USD 91.8 billion in 2016. The market is anticipated to grow to USD 151 billion by 2025, growing at a CAGR of 5.8% from 2017 to 2025.
  • Chemical control approach dominated the market in 2016 followed by mechanical & physical, biological, cultural, and others method.
  • Agricultural is largest application segment and is projected to follow the same growth trend over the forecast period.
  • The North America and Europe region was the largest regional market with a combined share of over 56%.
  • Asia Pacific region is anticipated to have the fastest growth. the region is projected to grow at a CAGR of 6.4% from 2017 to 2025.
  • The industry is dominated by a few multinational corporations such as BASF SE, Advanced Integrated Pest Management, IPM Pest Control, SGS SA, MB Integrated Pest Control, Bayer CropScience LP, Ecolab Inc., IPM Technologies Pty Ltd, and Integrated Pest Management Solution (IPMS India).
Grand View Research has segmented the global integrated pest management market by pest type, control method, application, and region:
Integrated Pest Management Pest Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Weeds
  • Invertebrates
  • Pathogens
  • Vertebrates
Integrated Pest Management Control Method Outlook (Revenue, USD Million, 2014 - 2025)
  • Biological Control
  • Chemical Control
  • Cultural Controls
  • Mechanical & Physical Controls
  • Other Control Method
Integrated Pest Management Application Outlook (Revenue, USD Million, 2014 - 2025)
  • Agriculture
  • Commercial buildings
  • Industrial
  • Residential
  • Others
Integrated Pest Management Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • UK
    • Netherland
    • Germany
  • Asia Pacific
    • China
    • India
  • Central & South America
    • Brazil
  • Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com
at No comments:

Smart Healthcare Market Is Anticipated To Grow Up Aound USD 225.54 Billion By 2022: Grand View Research, Inc.

The Global Smart Healthcare Market is expected to reach USD 225.54 Billion by 2022, according to a new study by Grand View Research, Inc. Rapid technological advancements in healthcare IT is expected to remain a key driving factor of the global smart healthcare market over the forecast period. Growing implementation of inventory management systems such as RFID KanBan and RFID smart cabinets aimed at curbing inventory costs and ensure appropriate logistics management is expected to boost the growth of the smart healthcare market.



Development of smart syringes, smart pills and smart bandages which enable remote monitoring of patients, help in diagnosing gastrointestinal diseases and infection spread minimization and remote monitoring of healing processes is expected to strengthen the platform for future market growth. On the other hand, high capital investments and poor awareness levels among consumers are some challenges faced by manufacturers.

mHealth is expected to register the fastest growth of over 40.0% over the forecast period.  Key factors likely to drive segment growth include rapidly increasing incidence rates of chronic diseases, increasing smart phone penetration rates and heightening need to ensure improved healthcare outcomes.

Access Full Research Report on Smart Healthcare Market www.grandviewresearch.com/industry-analysis/smart-healthcare-market

Further key findings from the study suggest:
  • Electronic health record (EHR) emerged as the largest product segment in terms of revenue and was estimated at over USD 19.50 billion in 2014. Implementation of the American Recovery and Reinvestment Act (ARRA) and HITECH Act is expected to make significant contributions towards segment growth. Key feature of HITECH Act includes the provision of USD 64,000 per year to healthcare practitioners adopting EHR systems.
  • North America was the largest smart healthcare regional market in 2014. Presence of favorable government initiatives in the form of HITECH Act providing allowances to healthcare practitioners is one of the major factors expected to drive regional market growth. Presence of sophisticated IT infrastructure enabling easy implementation of advanced healthcare facilities is also expected to boost market growth over the forecast period.
  • Asia Pacific is expected to grow at a considerable pace over the forecast period owing to growing penetration of advanced healthcare facilities and rapidly evolving mobile & IT infrastructure. Increasing awareness among consumers pertaining to novel healthcare technologies such as telemedicine, mHealth and EHR is expected to further complement regional market growth.
  • Key players operating in the smart healthcare market include Cisco, IBM, Olympus Corp., GE Healthcare, AT&T Inc., Apple Inc., Samsung Electronics, Logi-Tag, Wurth Group, AirStrip Technologies Inc., Allscripts Healthcare Solutions Inc., Pepperl+Fuchs and Given Imaging Inc.
Grand View Research has segmented the smart healthcare market on the basis of product, and region:
Global Smart Healthcare Product Outlook (Revenue, USD Million, 2014 - 2022)
  • RFID KanBan systems
  • RFID smart cabinets
  • Electronic Health Records (EHR)
    • Client-server based
    • Web-based
  • Telemedicine
    • Hardware
    • Connectivity and network
    • Others
  • mHealth
    • Monitoring services
    • Diagnosis services
    • Healthcare systems
    • Others
  • Smart pills
  • Smart syringes
Smart Healthcare  Regional Outlook (Revenue, USD Million, 2014 - 2022)
  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • MEA
    • South Africa
  • Latin America
    • Brazil
    • Mexico
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com
at No comments:

Viral Inactivation Market Is To Be $5.1 Billion by 2025 | CAGR: 12.5%: Grand View Research, Inc.

The global Viral Inactivation Market is anticipated to reach USD 5.1 billion by 2025, growing at a CAGR of 12.5%, according to a new report by Grand View Research, Inc. Rise in the number of pharmaceutical and biopharmaceutical companies, increase in FDA drug approvals, growth of the life sciences industry, increase in government funding for novel therapies, and drug development are some of the major factors contributing to the growth.


Immense growth has been witnessed in the pharmaceutical and biopharmaceutical industry with a steady rise in the number of companies, drug launches, and new drug discoveries. With an increase in the number of diseases worldwide, the need for new & improved drugs and therapies has been witnessed on a global front. Increase in investment by top players in research and development coupled with the need to find new therapies for the treatment of diseases has contributed to immense growth of pharmaceutical and biopharmaceutical companies, thereby accelerating growth.

Newer drugs are being developed by companies to offer incremental health benefits. Changing lifestyle of people across the globe and adoption of sedentary living habits are primary reasons responsible for the increase in the number of chronic diseases that require drugs and therapies for treatment. According to the FDA, in the year 2014, 41 novel drugs were approved and 45 in the consequent year. This has also been contributing to growth.

Immense funding has been witnessed in the pharmaceutical and biotechnology industries in the recent years. It has been observed that private players are the major contributors for the development of new drugs and therapies, however, there has been increasing government spending on the research and development of new therapies. Increase in funding has also resulted in growth in number of FDA approvals over the recent years. All these factors have been contributing to the immense growth of the market.

Access Full Research Report on Viral Inactivation Market
www.grandviewresearch.com/industry-analysis/viral-inactivation-market

Further Key Findings From the Study Suggest:
  • Kits and reagents held the largest share owing to increasing usage of consumables
  • Vaccines and therapeutics held the largest share, on the basis of application, and is expected to be the fastest growing segment due to the increased demand for biologics
  • The services segment is anticipated to grow at the fastest rate due to increase in the number of pharmaceutical CROs globally
  • North America accounted for the largest share owing to presence of dominant players and availability of sophisticated infrastructure along with healthcare reforms to curb the incidence of chronic diseases
  • The Asia Pacific region is expected to flourish during the forecast period owing to healthcare reforms and untapped market opportunities in the pharmaceutical industry

Grand View Research has segmented the global viral inactivation market on the basis of product, application, end use, and region:
Viral Inactivation Product Outlook (Revenue, USD Million; 2014 - 2025)
  • Kits and Reagents
  • Systems
  • Services
Viral Inactivation Application Outlook (Revenue, USD Million; 2014 - 2025)
  • Vaccines and Therapeutics
  • Stem Cell Products
  • Blood Tissue/Tissue Products
  • Blood and Blood Products
  • Cellular and Gene Therapy
Viral Inactivation End-use Outlook (Revenue, USD Million; 2014 - 2025)
  • Pharmaceutical and Biopharmaceutical Companies
  • CROs
  • Academic and Research Institutes
  • Others 
Viral Inactivation Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com
at No comments:
Subscribe to: Posts (Atom)

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

The global  mHealth apps market  size is expected to reach USD 236.0 billion by 2026, according to a new report by Grand View Research, In...